ESTA
Price
$70.69Alerts
Change
+$3.46 (+5.15%)
Updated
Nov 11 closing price
Capitalization
2B
110 days until earnings call
Intraday BUY SELL Signals
LIVN
Price
$90.98Alerts
Change
-$0.16 (-0.18%)
Updated
Nov 11 closing price
Capitalization
4.96B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESTA vs LIVN

ESTA vs LIVN Comparison Chart in %
View a ticker or compare two or three
VS
ESTA vs. LIVN commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESTA is a StrongBuy and LIVN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ESTA with price predictions
Nov 11, 2026

ESTA in upward trend: price rose above 50-day moving average on November 06, 2026

ESTA moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 47 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ESTA's RSI Oscillator exited the oversold zone, 20 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ESTA as a result. In 79 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for ESTA just turned positive on October 20, 2026. Looking at past instances where ESTA's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.

Following a +6.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESTA advanced for three days, in 240 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for ESTA moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

ESTA broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ESTA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ESTA's P/B Ratio (92.439) is very high in comparison to the industry average of (4.142). P/E Ratio (-52.772) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.749) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. ESTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for LIVN with price predictions
Nov 11, 2026

LIVN in -1.76% downward trend, declining for three consecutive days on November 11, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where LIVN declined for three days, in 228 of 308 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LIVN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 16 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 59 cases where LIVN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

LIVN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on LIVN as a result. In 55 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for LIVN just turned positive on October 09, 2026. Looking at past instances where LIVN's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

LIVN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LIVN crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in 206 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 109 of 186 cases where LIVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.741) is normal, around the industry mean (4.142). P/E Ratio (26.084) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.954) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

FUNDAMENTALS RATINGS
ESTA vs LIVN: Fundamental Ratings
ESTA
LIVN
OUTLOOK RATING
1..100
2985
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
75
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
9955
PRICE GROWTH RATING
1..100
5437
P/E GROWTH RATING
1..100
1579
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESTA's Valuation (12) in the Medical Specialties industry is somewhat better than the same rating for LIVN (75). This means that ESTA’s stock grew somewhat faster than LIVN’s over the last 12 months.

LIVN's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as ESTA (100). This means that LIVN’s stock grew similarly to ESTA’s over the last 12 months.

LIVN's SMR Rating (55) in the Medical Specialties industry is somewhat better than the same rating for ESTA (99). This means that LIVN’s stock grew somewhat faster than ESTA’s over the last 12 months.

LIVN's Price Growth Rating (37) in the Medical Specialties industry is in the same range as ESTA (54). This means that LIVN’s stock grew similarly to ESTA’s over the last 12 months.

ESTA's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for LIVN (79). This means that ESTA’s stock grew somewhat faster than LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESTALIVN
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ESTA: $70.69 vs. LIVN: $90.98)
Brand notoriety: ESTA and LIVN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ESTA: 88% vs. LIVN: 60%
Market capitalization -- ESTA: $2B vs. LIVN: $4.96B
ESTA [@Medical/Nursing Services] is valued at $2B. LIVN’s [@Medical/Nursing Services] market capitalization is $4.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESTA’s FA Score shows that 2 FA rating(s) are green while LIVN’s FA Score has 0 green FA rating(s).

  • ESTA’s FA Score: 2 green, 3 red.
  • LIVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ESTA is a better buy in the long-term than LIVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESTA’s TA Score shows that 5 TA indicator(s) are bullish while LIVN’s TA Score has 6 bullish TA indicator(s).

  • ESTA’s TA Score: 5 bullish, 5 bearish.
  • LIVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LIVN is a better buy in the short-term than ESTA.

Price Growth

ESTA (@Medical/Nursing Services) experienced а +5.60% price change this week, while LIVN (@Medical/Nursing Services) price change was -3.41% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

ESTA is expected to report earnings on Mar 02, 2027.

LIVN is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ESTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESTA has been loosely correlated with NPCE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ESTA jumps, then NPCE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESTA
1D Price
Change %
ESTA100%
+5.15%
NPCE - ESTA
48%
Loosely correlated
-1.34%
RDNT - ESTA
41%
Loosely correlated
+0.18%
NVST - ESTA
39%
Loosely correlated
-2.01%
LIVN - ESTA
37%
Loosely correlated
-0.18%
NTRA - ESTA
37%
Loosely correlated
+2.51%
More

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
-0.18%
CRL - LIVN
48%
Loosely correlated
-0.90%
UFPT - LIVN
45%
Loosely correlated
+0.00%
PHG - LIVN
44%
Loosely correlated
-0.69%
OFIX - LIVN
43%
Loosely correlated
+0.84%
STE - LIVN
43%
Loosely correlated
-0.33%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AXTL0.900.25
+39.23%
Leverage Shares 2X Long AXTI Daily ETF (AXTL)
SDTY39.570.56
+1.43%
YieldMax S&P 500 0DTE Covered Call Strategy ETF (SDTY)
NMAI13.890.18
+1.31%
Nuveen Multi-Asset Income Fund
WTV108.300.83
+0.77%
WisdomTree US Value Fund of Benef Interest (WTV)
GEW56.100.43
+0.77%
Cambria Global EW ETF (GEW)